echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Privat and FIND have reached a strategic partnership to jointly promote the development of women's health industries in low- and middle-income countries

    Privat and FIND have reached a strategic partnership to jointly promote the development of women's health industries in low- and middle-income countries

    • Last Update: 2022-09-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Guangzhou Privat Technology Co.


    Decentralized


    Privat and FIND will carry out strategic cooperation around the decentralization of molecular detection platforms to improve the level of health care in low- and middle-income areas and make diagnostic technology universally accessible to all


    "Covid-19 has accelerated technological development and has had a huge impact on


    Help the sinking


    As a new generation of molecular POC detection platform, Priva MiniDock has the characteristics of precision, convenience and decentralization, helping medical resources sink and making the application scenarios more extensive


    "Promoting the innovation of diagnostic technology and giving people in low- and middle-income areas equal rights to high-quality diagnostic tools is a common goal of us and FIND," said Mr.


    About FIND

    As the Global Diagnostics Alliance, the Foundation for Innovative Diagnostics (FIND) aims to ensure that reliable diagnosis


    About Privat

    Founded in 2017 and located in Guangzhou, Yangcheng, Privat is committed to using a new generation of genetic technology to develop independent and innovative molecular diagnostic products, providing complete solutions from core protein research and development, molecular detection methodology research and development, to molecular POCT detection products


    Privat was founded by the first batch of national high-level imported talents, the team consists of a number of professors, postdoctoral fellows, senior talents in the collective external diagnostic industry and protein engineering industry, and more than 60% of employees are currently engaged in R&D related positions


    Based on the breakthrough independent intellectual property rights OF RHAM technology, Privat has developed molecular POCT instruments and detection card products
    for human respiratory tract infections, reproductive tract infections, pet disease detection and so on.
    Privat has applied for more than 80 patents and authorized more than 20 patents around a variety of technologies; 15 test kits are CE certified and 1 is IVDR certified
    .
    For more details, please visit the

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.